JFL LIFE SCIENCES LIMITED Valuation
JFLLIFE · Healthcare · Current price ₹10.55
Is JFL LIFE SCIENCES LIMITED undervalued?
DocStoX estimates the fair value of JFL LIFE SCIENCES LIMITED at ₹19 per share, versus the current market price of ₹11. That puts the stock about +77.1% below our fair-value estimate, which we read as "Strong Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹14), Relative P/E (₹29), Graham floor (₹17). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹14 (bear) to ₹19 (base) to ₹29 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
JFL LIFE SCIENCES LIMITED trades at a P/E of 10.9x and a P/B of 0.8x, with a dividend yield of 2.3%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on JFL LIFE SCIENCES LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.